BioNexus Gene Lab Corp.: 10-Q filed 2019-05-15
What BioNexus Gene Lab Corp. reported in its quarterly report filed 2019-05-15 (fiscal Q1 2019): 22 published measures, 42 facts as tagged in accession 0001551163-19-000126.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-05-15
- Fiscal period
- fiscal Q1 2019
- Accession
- 0001551163-19-000126 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioNexus Gene Lab Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 1,607,160 | USD | |
| At 2018-12-31 | 1,652,239 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 129,556 | USD | |
| At 2018-12-31 | 130,313 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 1,477,604 | USD | |
| At 2018-12-31 | 1,521,926 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2018-12-31 | 1,260,239 | USD | |
| At 2017-12-31 | 839,145 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -61,467 | USD | 90 |
| 2018-01-01 to 2018-03-31 | 271,861 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -48,561 | USD | 90 |
| 2018-01-01 to 2018-03-31 | -673,561 | USD | 90 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | 28,088 | USD | 90 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -3,606 | USD | 90 |
| 2018-01-01 to 2018-03-31 | 1,116,681 | USD | 90 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -14,631 | USD | 90 |
| 2018-01-01 to 2018-03-31 | -30,134 | USD | 90 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -1,264 | USD | 90 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 345,122 | USD | |
| At 2018-12-31 | 341,805 | USD |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 1,249,788 | USD | |
| At 2018-12-31 | 1,298,354 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 66,182 | USD | |
| At 2018-12-31 | 62,893 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 10,050 | USD | |
| At 2018-12-31 | 15,301 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | 9,266 | USD | 90 |
| 2018-01-01 to 2018-03-31 | -12,530 | USD | 90 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -18,822 | USD | 90 |
| 2018-01-01 to 2018-03-31 | -12,530 | USD | 90 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | -5,011,891 | USD | |
| At 2018-12-31 | -5,011,891 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | -9,832 | USD | |
| At 2018-12-31 | -26,977 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -61,467 | USD | 90 |
| 2018-01-01 to 2018-03-31 | 271,861 | USD | 90 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -44,502 | USD | 90 |
| 2018-01-01 to 2018-03-31 | 273,614 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -76,489 | USD | 90 |
| 2018-01-01 to 2018-03-31 | -36,588 | USD | 90 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | 5,251 | USD | 90 |
| 2018-01-01 to 2018-03-31 | -9,423 | USD | 90 |
Inspect the source
- Entity
- BioNexus Gene Lab Corp. / CIK 0001737523
- Captured
- 2026-09-21T17:25:37.348Z
- SEC response SHA-256
eebcf668b9e42f0c31bf1fe5b3c17450d7f4d836f715c9cebcc6a4fafbcff983
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001737523.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))